Shuttle Pharmaceuticals Holdings (SHPH) said Tuesday it has appointed Timothy Lorber as chief financial officer, succeeding Michael Vander Hoek, who will assume the role of vice president of regulatory on a full-time basis.
Lorber will initially serve as part-time CFO through Sept. 9, and become full-time CFO starting Sept. 10, the company said.
Lorber more recently served in leadership roles with several privately held businesses, Shuttle Pharmaceuticals said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments